# Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Post Percutaneous Coronary Intervention (PCI).

> **NCT01109784** · PHASE3 · COMPLETED · sponsor: **University of Patras** · enrollment: 70 (estimated)

## Conditions studied

- Coronary Artery Disease (CAD)
- Acute Coronary Syndrome (ACS)

## Interventions

- **DRUG:** prasugrel
- **DRUG:** clopidogrel

## Key facts

- **NCT ID:** NCT01109784
- **Lead sponsor:** University of Patras
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2010-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01109784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01109784, "Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Post Percutaneous Coronary Intervention (PCI).". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01109784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*